Statement of Organization, Functions, and Delegations of Authority, 34437-34438 [2015-14686]
Download as PDF
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–14709 Filed 6–15–15; 8:45 am]
both CDC and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–14751 Filed 6–15–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
asabaliauskas on DSK5VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates:
9:00 a.m.–5:00 p.m., July 16, 2015
9:00 a.m.–12:00 p.m., July 17, 2015
Place: CDC, 1600 Clifton Rd., Global
Communications Center, Building 19,
Auditorium B, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, and the
Secretary, Health and Human Services
regarding (1) the practice of healthcare
infection prevention and control; (2)
strategies for surveillance, prevention, and
control of infections, antimicrobial
resistance, and related events in settings
where healthcare is provided; and (3)
periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda will
include updates on CDC’s activities for
prevention and control of healthcare
associated infections (HAIs), updates on
hospital antimicrobial stewardship activities,
an update on Draft Guideline to Prevent
Surgical Site Infections, infection control
practice improvements, and environmental
infection control.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 30076, dated
May 26, 2015) is amended to reflect the
reorganization of the National Institute
for Occupational Safety and Health,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and the
mission and function statements for the
National Personal Protective
Technology Laboratory (CCL) and insert
the following:
The National Personal Protective
Technology (NPPTL) (CCL) prevents
work-related injury, illness and death by
advancing the state of knowledge and
application of personal protective
technologies (PPT) including
instrumentation, respiratory protective
devices (RPD), and a diversity of
personal protective equipment (PPE)
used for the protection of American
workers. To accomplish this mission,
NPPTL leads and coordinates the
National Institute for Occupational
Safety and Health’s (NIOSH) programs,
projects, and policies related to PPT
across the Institute. NPPTL: (1)
Identifies the need for research,
conducts and coordinates research to
support the development of new
technologies, performance, quality and
reliability standards, Federal
regulations, safety and health criteria,
and Institute policy; (2) conducts a
variety of laboratory and field
investigations relating to the
development and evaluation of
innovative technologies; (3) directs,
implements, and provides national
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
34437
guidance related to conformity
assessment programs and functions (e.g.
inspection, testing, certification, quality
assurance, surveillance); (4) provides
national leadership serving on national
and international PPT consensus
standard setting committees; (5)
develops and promulgates standards
and regulations; (6) produces and
disseminates scientific reports and
national guidance documents including
research, laboratory and field studies,
safety and health investigations,
scientific criteria, and national
guidance; (7) designs and implements
information technology functions
including national or program
databases, trusted sources for public
information and social marketing; and
(8) coordinates program support
functions including budget, facilities,
growth initiatives, and communications,
and scientific support functions such as
Committee on Personal Protective
Equipment and Institute of Medicine
evaluations, special projects, nonrespiratory PPE conformity assessment,
and federal and consensus standards
across NIOSH.
Research Branch (CCLE). (1) Conducts
hypothesis testing-based PPT research
with an emphasis on respiratory
protection, protective clothing, and
ensemble research; (2) encourages and
conducts research related to innovative
technologies to improve the use and
usability of existing and new PPT
products; (3) conducts laboratory and
field research projects to measure
performance, quality, reliability, and
efficacy of the materials, components,
and sub-systems used in PPT as well as
complete equipment systems, especially
for new or emerging hazards, and
recommends criteria to improve the
selection, care, maintenance, and use of
PPT; (4) investigates emerging hazards
and personal exposures to identify
worker PPT needs and technology gaps;
(5) conducts research to identify and
recommend effective integration
strategies and evidence-based test
methods for PPT for use in PPT
standards; (6) recommends
performance, quality, reliability, and
efficacy criteria; (7) studies and
improves human/technology interfaces
to better understand and mitigate
barriers to effective PPT selection, care,
maintenance, and use; (8) conducts
laboratory and field-based research into
the biomechanical, physiological, and
psychological stressors and worker
responses to PPT; (9) conducts research,
developing interventions, and identifies
innovative methods (e.g., new software
tools, information technology, social
marketing, training methods, practices,
E:\FR\FM\16JNN1.SGM
16JNN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
34438
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
equipment, etc.) of increasing end-user
compliance with proper selection, care,
maintenance, and use of PPT; (10)
provides systematic collection, analysis,
and interpretation of PPT use practices,
including investigation of barriers to
effective PPT use; (11) produces and
disseminates technical information,
research findings, training materials,
and recommendations for PPT to
improve protection of workers; (12)
evaluates and disseminates PPT
performance trends published through
the post market surveillance activities;
and (13) identifies and implements an
effective communication and outreach
program for stakeholders within the
NIOSH sectors to inform end users of
proper selection, care, maintenance, and
use of PPT.
Conformity Verification and
Standards Development Branch (CCLG).
(1) Administers the Department of
Health and Human Services Title 42
Code of Federal Regulations (CFR), Part
84-Respiratory Protective Devices
conformity assessment functions (i.e.
inspection, testing, certification,
documentation control, quality
assurance, and surveillance) including:
(a) Processing respirator approval
applications by verifying conformance
with Federal regulations and national
consensus standards such as
performance, quality, reliability, and
documentation requirements to
determine the effectiveness of
respirators used during entry into or
escape from hazardous atmospheres, (b)
issuing or revoking NIOSH certificates
of approval, (c) evaluating and
maintaining official records on NIOSHcertified respirators including the
establishment of NPPTL and national
databases, (d) recommending NIOSH
policy relating to RPD conformity
verification criteria for traditional and
innovative respirator technologies and
applications, and, (e) investigating and
processing Freedom-of-Information-Act
requests; (2) establishes and administers
an internal audit program to evaluate
the conformity assessment functions of
NPPTL; (3) maintains official files of
policies, standards, standard operating
and test procedures used as the basis for
granting a NIOSH certificate of
approval; (4) provides national
recommendations for effective
conformity assessment programs
associated with non-respiratory PPT; (5)
assesses research findings and translates
them into effective conformity
assessment recommendations for
NIOSH policy, standards, regulations,
and surveillance practices, for new
protective technologies or special
applications of existing technologies; (6)
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
leads NIOSH participation in the
development and promulgation of
national and international consensus
standards, conformity assessment
program criteria and guidance,
establishment of Federal regulations
where necessary, and assesses of
economic impact of Federal regulations;
(7) prepares criteria for proper selection,
recommends national guidance for
effective use (e.g. cautions, limitations,
and restrictions of use) and
maintenance, and provides technical
support; (8) plans and conducts public
meetings to solicit or provide
information concerning technology and
conformity assessment practices; and (9)
prepares and disseminates national
reports related to conformity assessment
of PPT.
Evaluation and Testing Branch
(CCLH). (1) Conducts evaluations and
tests in accordance with prescribed
standard test procedures of RPD in
support of NIOSH conformity
assessment functions that lead to a
NIOSH certificate of approval or its
revocation; (2) conducts quality
management system in-plant
manufacturing-site evaluations
including post market surveillance, and
documents finding and
recommendations in proper reports; (3)
conducts evaluation and testing of PPT
for various purposes, and prepares
reports for dissemination to the public;
(4) provides testing support to the
NPPTL research and standards
development initiatives; (5) develops
evaluation methodologies, and unique
test procedures to address new
protective technologies or special
applications of existing technologies; (6)
conducts post market evaluations of
NIOSH-certified RPD including the
long-term field evaluation program, and
prepares technical information and
reports to improve standards for
certification, selection, care, and use; (7)
administers and conducts surveillance
of field deployed PPT to evaluate
conformance to applicable regulation,
consensus standards, and NIOSH
policy; (8) conducts investigations of
PPT associated with complaints of
nonconformance and/or concerns
related to adverse health and safety
including evaluations and analysis
associated with NIOSH-certified
respirators (e.g. certified product
investigation process), and evaluating
respirators and protective clothing
submitted in conjunction with the
NIOSH Fire Fighter Fatality
Investigation and Prevention Program
investigations conducted by the
Division of Safety Research ; and (9)
maintains and improves laboratory
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
capabilities to perform evaluation and
testing of PPT including innovative
technologies, implements a laboratory
quality program (e.g., ISO 17025) to
ensure quality and continuous
improvement of PPT evaluations and
tests, administers and maintains a chain
of custody program to secure
technologies or products obtained for
evaluation and testing, and conducts an
internal audit function to assure
evaluation and testing are carried out in
accordance policy and standard
procedures.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–14686 Filed 6–15–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date:
1:30 p.m.–2:30 p.m. (EDT), July 17, 2015
Place: This meeting will be held by
teleconference. To participate in the
teleconference, please dial (877) 930–8819
and enter code 1579739.
Status: Open to the public, limited only by
the availability of telephone ports. The
public is welcome to participate during the
public comment period, tentatively
scheduled from 2:20 p.m. until 2:25 p.m.
Purpose: The Advisory Committee to the
Director, CDC, shall advise the Secretary,
HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill
its mission of protecting health through
health promotion, prevention, and
preparedness. The committee recommends
ways to prioritize CDC’s activities, improve
results, and address health disparities. It also
provides guidance to help CDC work more
effectively with its various private and public
sector constituents to make health protection
a practical reality.
Matters for Discussion: The Advisory
Committee to the Director will receive an
update from the External Laboratory Safety
Workgroup.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, ACD, CDC, 1600 Clifton Road NE.,
M/S D–14, Atlanta, Georgia 30333;
E:\FR\FM\16JNN1.SGM
16JNN1
Agencies
[Federal Register Volume 80, Number 115 (Tuesday, June 16, 2015)]
[Notices]
[Pages 34437-34438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14686]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 80 FR 30076, dated May 26, 2015) is amended to
reflect the reorganization of the National Institute for Occupational
Safety and Health, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and the mission and function
statements for the National Personal Protective Technology Laboratory
(CCL) and insert the following:
The National Personal Protective Technology (NPPTL) (CCL) prevents
work-related injury, illness and death by advancing the state of
knowledge and application of personal protective technologies (PPT)
including instrumentation, respiratory protective devices (RPD), and a
diversity of personal protective equipment (PPE) used for the
protection of American workers. To accomplish this mission, NPPTL leads
and coordinates the National Institute for Occupational Safety and
Health's (NIOSH) programs, projects, and policies related to PPT across
the Institute. NPPTL: (1) Identifies the need for research, conducts
and coordinates research to support the development of new
technologies, performance, quality and reliability standards, Federal
regulations, safety and health criteria, and Institute policy; (2)
conducts a variety of laboratory and field investigations relating to
the development and evaluation of innovative technologies; (3) directs,
implements, and provides national guidance related to conformity
assessment programs and functions (e.g. inspection, testing,
certification, quality assurance, surveillance); (4) provides national
leadership serving on national and international PPT consensus standard
setting committees; (5) develops and promulgates standards and
regulations; (6) produces and disseminates scientific reports and
national guidance documents including research, laboratory and field
studies, safety and health investigations, scientific criteria, and
national guidance; (7) designs and implements information technology
functions including national or program databases, trusted sources for
public information and social marketing; and (8) coordinates program
support functions including budget, facilities, growth initiatives, and
communications, and scientific support functions such as Committee on
Personal Protective Equipment and Institute of Medicine evaluations,
special projects, non-respiratory PPE conformity assessment, and
federal and consensus standards across NIOSH.
Research Branch (CCLE). (1) Conducts hypothesis testing-based PPT
research with an emphasis on respiratory protection, protective
clothing, and ensemble research; (2) encourages and conducts research
related to innovative technologies to improve the use and usability of
existing and new PPT products; (3) conducts laboratory and field
research projects to measure performance, quality, reliability, and
efficacy of the materials, components, and sub-systems used in PPT as
well as complete equipment systems, especially for new or emerging
hazards, and recommends criteria to improve the selection, care,
maintenance, and use of PPT; (4) investigates emerging hazards and
personal exposures to identify worker PPT needs and technology gaps;
(5) conducts research to identify and recommend effective integration
strategies and evidence-based test methods for PPT for use in PPT
standards; (6) recommends performance, quality, reliability, and
efficacy criteria; (7) studies and improves human/technology interfaces
to better understand and mitigate barriers to effective PPT selection,
care, maintenance, and use; (8) conducts laboratory and field-based
research into the biomechanical, physiological, and psychological
stressors and worker responses to PPT; (9) conducts research,
developing interventions, and identifies innovative methods (e.g., new
software tools, information technology, social marketing, training
methods, practices,
[[Page 34438]]
equipment, etc.) of increasing end-user compliance with proper
selection, care, maintenance, and use of PPT; (10) provides systematic
collection, analysis, and interpretation of PPT use practices,
including investigation of barriers to effective PPT use; (11) produces
and disseminates technical information, research findings, training
materials, and recommendations for PPT to improve protection of
workers; (12) evaluates and disseminates PPT performance trends
published through the post market surveillance activities; and (13)
identifies and implements an effective communication and outreach
program for stakeholders within the NIOSH sectors to inform end users
of proper selection, care, maintenance, and use of PPT.
Conformity Verification and Standards Development Branch (CCLG).
(1) Administers the Department of Health and Human Services Title 42
Code of Federal Regulations (CFR), Part 84-Respiratory Protective
Devices conformity assessment functions (i.e. inspection, testing,
certification, documentation control, quality assurance, and
surveillance) including: (a) Processing respirator approval
applications by verifying conformance with Federal regulations and
national consensus standards such as performance, quality, reliability,
and documentation requirements to determine the effectiveness of
respirators used during entry into or escape from hazardous
atmospheres, (b) issuing or revoking NIOSH certificates of approval,
(c) evaluating and maintaining official records on NIOSH-certified
respirators including the establishment of NPPTL and national
databases, (d) recommending NIOSH policy relating to RPD conformity
verification criteria for traditional and innovative respirator
technologies and applications, and, (e) investigating and processing
Freedom-of-Information-Act requests; (2) establishes and administers an
internal audit program to evaluate the conformity assessment functions
of NPPTL; (3) maintains official files of policies, standards, standard
operating and test procedures used as the basis for granting a NIOSH
certificate of approval; (4) provides national recommendations for
effective conformity assessment programs associated with non-
respiratory PPT; (5) assesses research findings and translates them
into effective conformity assessment recommendations for NIOSH policy,
standards, regulations, and surveillance practices, for new protective
technologies or special applications of existing technologies; (6)
leads NIOSH participation in the development and promulgation of
national and international consensus standards, conformity assessment
program criteria and guidance, establishment of Federal regulations
where necessary, and assesses of economic impact of Federal
regulations; (7) prepares criteria for proper selection, recommends
national guidance for effective use (e.g. cautions, limitations, and
restrictions of use) and maintenance, and provides technical support;
(8) plans and conducts public meetings to solicit or provide
information concerning technology and conformity assessment practices;
and (9) prepares and disseminates national reports related to
conformity assessment of PPT.
Evaluation and Testing Branch (CCLH). (1) Conducts evaluations and
tests in accordance with prescribed standard test procedures of RPD in
support of NIOSH conformity assessment functions that lead to a NIOSH
certificate of approval or its revocation; (2) conducts quality
management system in-plant manufacturing-site evaluations including
post market surveillance, and documents finding and recommendations in
proper reports; (3) conducts evaluation and testing of PPT for various
purposes, and prepares reports for dissemination to the public; (4)
provides testing support to the NPPTL research and standards
development initiatives; (5) develops evaluation methodologies, and
unique test procedures to address new protective technologies or
special applications of existing technologies; (6) conducts post market
evaluations of NIOSH-certified RPD including the long-term field
evaluation program, and prepares technical information and reports to
improve standards for certification, selection, care, and use; (7)
administers and conducts surveillance of field deployed PPT to evaluate
conformance to applicable regulation, consensus standards, and NIOSH
policy; (8) conducts investigations of PPT associated with complaints
of nonconformance and/or concerns related to adverse health and safety
including evaluations and analysis associated with NIOSH-certified
respirators (e.g. certified product investigation process), and
evaluating respirators and protective clothing submitted in conjunction
with the NIOSH Fire Fighter Fatality Investigation and Prevention
Program investigations conducted by the Division of Safety Research ;
and (9) maintains and improves laboratory capabilities to perform
evaluation and testing of PPT including innovative technologies,
implements a laboratory quality program (e.g., ISO 17025) to ensure
quality and continuous improvement of PPT evaluations and tests,
administers and maintains a chain of custody program to secure
technologies or products obtained for evaluation and testing, and
conducts an internal audit function to assure evaluation and testing
are carried out in accordance policy and standard procedures.
James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-14686 Filed 6-15-15; 8:45 am]
BILLING CODE 4163-18-P